tiprankstipranks
Trending News
More News >
BB Biotech AG (GB:0JYO)
LSE:0JYO
UK Market

BB Biotech (0JYO) Ratios

Compare
3 Followers

BB Biotech Ratios

GB:0JYO's free cash flow for Q2 2025 was CHF1.00. For the 2025 fiscal year, GB:0JYO's free cash flow was decreased by CHF and operating cash flow was CHF0.07. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
758.29 158.32 <0.01 <0.01 0.11
Quick Ratio
758.29 158.32 <0.01 <0.01 52.45
Cash Ratio
0.89 0.03 <0.01 <0.01 0.09
Solvency Ratio
-202.38 -1.19 -1.83 -2.11 10.97
Operating Cash Flow Ratio
179.09 13.10 -0.97 -0.26 3.47
Short-Term Operating Cash Flow Coverage
0.00 0.00 0.00 0.00 0.00
Net Current Asset Value
CHF 1.84BCHF 2.32BCHF -365.31MCHF -352.17MCHF -54.66M
Leverage Ratios
Debt-to-Assets Ratio
0.00 0.12 0.12 0.10 0.02
Debt-to-Equity Ratio
0.00 0.13 0.14 0.11 0.02
Debt-to-Capital Ratio
0.00 0.12 0.12 0.10 0.02
Long-Term Debt-to-Capital Ratio
0.00 0.00 0.12 0.00 0.00
Financial Leverage Ratio
1.00 1.14 1.14 1.11 1.02
Debt Service Coverage Ratio
-0.03 -34.70 -207.04 -408.58 782.76
Interest Coverage Ratio
-25.67 -5.16 -206.27 -410.49 782.84
Debt to Market Cap
0.00 0.00 0.12 0.00 0.00
Interest Debt Per Share
0.04 5.67 6.63 6.43 1.15
Net Debt to EBITDA
0.00 -1.51 -1.01 -0.87 0.08
Profitability Margins
Gross Profit Margin
100.00%100.00%100.00%100.00%100.00%
EBIT Margin
-22.78%100.58%101.37%101.90%99.25%
EBITDA Margin
0.00%100.85%101.73%101.66%98.86%
Operating Profit Margin
29.55%15.00%101.37%102.15%98.86%
Pretax Profit Margin
249.02%103.49%101.86%102.15%98.86%
Net Profit Margin
249.05%103.53%101.87%102.17%98.85%
Continuous Operations Profit Margin
249.05%103.53%101.87%102.17%98.85%
Net Income Per EBT
100.01%100.04%100.02%100.02%99.99%
EBT Per EBIT
842.57%690.08%100.48%100.00%100.00%
Return on Assets (ROA)
-23.78%-7.83%-11.72%-11.11%17.44%
Return on Equity (ROE)
-21.14%-8.89%-13.32%-12.33%17.78%
Return on Capital Employed (ROCE)
-2.83%-1.14%-13.25%-12.33%17.78%
Return on Invested Capital (ROIC)
-2.83%-0.57%-13.26%-12.33%17.78%
Return on Tangible Assets
-23.78%-7.83%-11.72%-11.11%17.44%
Earnings Yield
-19.65%-8.82%-11.78%-9.48%16.83%
Efficiency Ratios
Receivables Turnover
0.00 -109.11 0.00 0.00 0.00
Payables Turnover
0.00 0.00 0.00 0.00 0.00
Inventory Turnover
0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
0.00 0.00 0.00 0.00 0.00
Asset Turnover
-0.10 -0.08 -0.12 -0.11 0.18
Working Capital Turnover Ratio
-0.09 -0.18 0.97 1.86 -34.88
Cash Conversion Cycle
0.00 -3.35 0.00 0.00 0.00
Days of Sales Outstanding
0.00 -3.35 0.00 0.00 0.00
Days of Inventory Outstanding
0.00 0.00 0.00 0.00 0.00
Days of Payables Outstanding
0.00 0.00 0.00 0.00 0.00
Operating Cycle
0.00 -3.35 0.00 0.00 0.00
Cash Flow Ratios
Operating Cash Flow Per Share
7.95 3.98 -6.50 -1.71 4.74
Free Cash Flow Per Share
7.95 3.98 -6.50 -1.71 4.74
CapEx Per Share
0.00 0.00 0.00 0.00 0.00
Free Cash Flow to Operating Cash Flow
1.00 1.00 1.00 1.00 1.00
Dividend Paid and CapEx Coverage Ratio
4.42 1.40 -1.69 -0.48 1.39
Capital Expenditure Coverage Ratio
0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Coverage Ratio
0.00 0.72 -0.99 -0.27 4.17
Operating Cash Flow to Sales Ratio
-2.47 -1.09 1.02 0.24 0.38
Free Cash Flow Yield
19.53%9.32%-11.78%-2.22%6.39%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-5.09 -11.34 -8.49 -10.55 5.94
Price-to-Sales (P/S) Ratio
-12.67 -11.74 -8.65 -10.78 5.87
Price-to-Book (P/B) Ratio
1.21 1.01 1.13 1.30 1.06
Price-to-Free Cash Flow (P/FCF) Ratio
5.12 10.73 -8.49 -45.06 15.65
Price-to-Operating Cash Flow Ratio
5.12 10.73 -8.49 -45.06 15.65
Price-to-Earnings Growth (PEG) Ratio
1.72 0.27 0.77 0.07 2.91
Price-to-Fair Value
1.21 1.01 1.13 1.30 1.06
Enterprise Value Multiple
0.00 -13.15 -9.51 -11.48 6.02
Enterprise Value
2.23B 2.65B 3.40B 4.62B 4.16B
EV to EBITDA
0.00 -13.15 -9.51 -11.48 6.02
EV to Sales
-12.66 -13.26 -9.67 -11.67 5.95
EV to Free Cash Flow
5.12 12.13 -9.50 -48.78 15.86
EV to Operating Cash Flow
5.12 12.13 -9.50 -48.78 15.86
Tangible Book Value Per Share
33.64 42.39 48.83 59.41 70.41
Shareholders’ Equity Per Share
33.64 42.39 48.83 59.31 70.18
Tax and Other Ratios
Effective Tax Rate
>-0.01 >-0.01 >-0.01 >-0.01 <0.01
Revenue Per Share
-3.22 -3.64 -6.38 -7.16 12.62
Net Income Per Share
-8.01 -3.77 -6.50 -7.31 12.48
Tax Burden
1.00 1.00 1.00 1.00 1.00
Interest Burden
-10.93 1.03 1.00 1.00 1.00
Research & Development to Revenue
0.00 0.00 0.00 0.00 0.00
SG&A to Revenue
-0.15 -0.02 -0.01 -0.02 <0.01
Stock-Based Compensation to Revenue
0.00 0.00 0.00 0.00 0.00
Income Quality
-10.74 -1.06 1.00 0.23 0.38
Currency in CHF